DadFinStart your free weekStarling Oncology, Inc. (STLN) stock score
$6.63 ▲ +7.28% today
Starling Oncology, Inc. (STLN) is a Medical Care Facilities company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 60.5 out of 100 on the Dad Score, a middling reading that places the business ahead of 60% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #337 of 974. Its strongest axes are valuation, quality and growth; its weakest are risk and liquidity.
Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →
The eight axes
Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.
Key numbers
What subscribers see on STLN
- Value Score: is the price right for this business, the score the Value book is selected on.
- Trader Score: is it set up to move, refreshed every 15 minutes in the session.
- The full eight-axis breakdown, every input and its percentile.
- SEC filings, insider buying, earnings history and peers side by side.
- Whether it is in this week's published books, with the receipts.
Medical Care Facilities peers
| Stock | Company | Dad Score | Band |
|---|---|---|---|
| HCA | HCA Healthcare, Inc. | 94.4 | strong |
| THC | Tenet Healthcare Corporation | 85.2 | strong |
| FMS | Fresenius Medical Care AG | 64.4 | middling |
| EHC | Encompass Health Corporation | 90.0 | strong |
| DVA | DaVita Inc. | 70.5 | good |
| UHS | Universal Health Services, Inc. | 96.7 | strong |
| ENSG | The Ensign Group, Inc. | 78.9 | good |
| PACS | PACS Group, Inc. | 82.5 | good |
Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.